NSE Circulars (2231)
National Stock Exchange of India circulars including trading guidelines, compliance requirements, market operations updates, and regulatory changes affecting market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE updates the list of privately issued corporate bonds eligible for DVP-3 settlement on the institutional platform of the debt segment, … | |||||||||||||||
NSE updates the list of privately issued corporate bonds eligible for DVP-3 settlement on the institutional platform of the debt segment, including bonds from REC, HDFC Bank, IRFC, Tata Capital Housing Finance, and other major issuers.
| |||||||||||||||
NSE Clearing revises position limits for WEBELSOLAR in Securities Lending and Borrowing Scheme, increasing market-wide position limit … | |||||||||||||||
NSE Clearing revises position limits for WEBELSOLAR in Securities Lending and Borrowing Scheme, increasing market-wide position limit 10-fold effective November 17, 2025.
| |||||||||||||||
NSE Clearing has revised the market wide position limits, trading member-wise position limits, and FII/FPI and mutual fund position limits … | |||||||||||||||
NSE Clearing has revised the market wide position limits, trading member-wise position limits, and FII/FPI and mutual fund position limits for ADANI ENTERPRISES LIMITED effective November 17, 2025.
| |||||||||||||||
NSE announces adjustments to ADANIENT futures and options contracts due to rights issue at 3:25 ratio and Rs 1800 issue price, effective … | |||||||||||||||
NSE announces adjustments to ADANIENT futures and options contracts due to rights issue at 3:25 ratio and Rs 1800 issue price, effective November 17, 2025.
| |||||||||||||||
NSE Clearing publishes settlement calendar for the takeover offer of J.B. Chemicals & Pharmaceuticals Limited with trading period from … | |||||||||||||||
NSE Clearing publishes settlement calendar for the takeover offer of J.B. Chemicals & Pharmaceuticals Limited with trading period from November 18 to December 1, 2025.
| |||||||||||||||
NSE suspends trading in IIFL Finance Limited NCD (ISIN: INE530B07419) effective November 17, 2025 due to redemption for exercising call … | |||||||||||||||
NSE suspends trading in IIFL Finance Limited NCD (ISIN: INE530B07419) effective November 17, 2025 due to redemption for exercising call option.
| |||||||||||||||
Curis Lifesciences Limited securities to be transferred from trade for trade segment (ST) to rolling segment (SM) effective November 28, … | |||||||||||||||
Curis Lifesciences Limited securities to be transferred from trade for trade segment (ST) to rolling segment (SM) effective November 28, 2025.
| |||||||||||||||
DALMIASUG to be transferred from trade for trade segment (series: BE) to rolling segment (series: EQ) effective November 17, 2025. | |||||||||||||||
DALMIASUG to be transferred from trade for trade segment (series: BE) to rolling segment (series: EQ) effective November 17, 2025.
| |||||||||||||||
NSE announces securities under Long Term Additional Surveillance Measure with 100% margin requirement effective November 18, 2025. Sahasra … | |||||||||||||||
NSE announces securities under Long Term Additional Surveillance Measure with 100% margin requirement effective November 18, 2025. Sahasra Electronic Solutions Limited moves from Stage-I to Stage-II.
| |||||||||||||||
NSE introduces Enhanced Surveillance Measure for Jay Jalaram Technologies Limited with 100% margin requirement and shift to Trade-for-Trade … | |||||||||||||||
NSE introduces Enhanced Surveillance Measure for Jay Jalaram Technologies Limited with 100% margin requirement and shift to Trade-for-Trade segment effective November 17, 2025.
| |||||||||||||||